News About: Pharm. Industry
Zuellig to cancel Cialis margin rate down.
Zuellig and Lilly Korea agreed to withdraw the lower margin rate policy on Cialis and notified it to all member wholesalers in the metropolitan areas and Busan and Gyeong-nam area who raised harsh challenges against Z...
KFDA to reinforce control for clinical test institutes.
The KFDA announced "Optimizing plan for the inspection of clinical test institutes" in order that the clinical study institutes would be more scrutinized.
The Drug Review Division and the Drug Safety Bureau of KF...
Mr. Koen Kruytbosch to name president of Organon Korea.Mr. Koen Kruytbosch was assigned to the president of Organon Korea, who was born in Netherlands, having an international business career working at Belgium, Canada and Denmarks ...
|
Choongwe's new bio drug for stroke using stem cells on phase III study.
Choongwe exchanged a memorandum of understanding with FCB Pharmaicell FCBP) on June 30 jointly to develope a new drug for the treatment of stroke using stem cells, for which FCBP obtained an IND from the KFDA for its ...
Top 100 companies produced 86% of drugs in 2004.
According to the statistics compiled by the Korea Pharmaceutical Manufacturers Association, the total production in 2004 was amounted to 10,452,600 million won, of which the top 100 companies produced 86.22% (9,012,30...
Novartis and Yuhan disputing on trademark Famvics.
Novartis appealed to the Korea Patent Office on July 1 against the trade market application of Famvics (appl. no. 40-2004-0019914) filed by Yuhan who intended to use Famvics (famciclovir) for the treatment of shingles...
MSD Korea to launch Vytorin for an anti-cholestrolemia.
MSD Korea announced to launch Vytorin, a new type of anti-cholesterol drug containing 2 medicines, ezetimibe and simvastatin, blocking cholesterol absorption in duplicate in the process of cholesterol synthesis in the...
Wholesale industry needs fast and powerful M&A policies.
President Christian Stockling of Zuellig Pharma Korea, who leaves Korea for the top executive position of Zuellig Indonesia soon, advised to the Korean pharmaceutical wholesale industry that far more powerful and fast...
Choongwe and Yuhan to list 30 most respectful firms
Choongwe has been appointed as the 30 most respectful Korean enterprisers in 2005 by Dong-A daily news, IBM Korea and BCS (Business Consulting Service).
The nomination has been 2 years by Dong-A daily news company,...
Impotence drug Zydena to launch on Aug. 15
Dong-A announced to launch Zydena, the first impotence drug developed in Korea, at 9 a.m. on Aug. 15 this year as implied in its code number DA-8159.
August 15 is the day for the Koreans to recover the nation's pr...